Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Welmoxy CV
Welmoxy CV (Amoxycillin Potassium Clavulanate Injection 1.2g) is a potent antibiotic combination that treats a wide range of bacterial infections, including those caused by resistant bacteria.
Uses of Welmoxy CV
Treatment of severe bacterial infections (pneumonia, UTIs, soft tissue infections)
Effective against beta-lactamase-producing bacteria
Management of intra-abdominal and respiratory tract infections
Used in critically ill or hospitalized patients with high infection risk
Benefits of Welmoxy CV
Broad-spectrum activity against Gram-positive and Gram-negative bacteria
Clavulanate prevents bacterial resistance by inhibiting beta-lactamase enzymes
Rapid intravenous administration for fast therapeutic effect
Well-tolerated with proven clinical efficacy
Mechanism of Action of Welmoxy CV
Amoxycillin inhibits bacterial cell wall synthesis, leading to bacterial cell death.
Clavulanate inhibits beta-lactamases, protecting amoxycillin from bacterial resistance and enhancing its antimicrobial activity.